The company is planning to issue 1.5 million units of shares at a face value of Rs 100.
In this regard, the company has appointed Global IME Capital as issue manager.
The agreement was signed on April 10 by Udhab Prasad Mainali, Chairman of Arrow Pharmaceuticals and Mandip Luitel, CEO of Global IME Capital in the premises of the capital.
The company with rs 1 billion in authorized and Rs 750 million in issued capital has corporate office at ward no 3, Basundhara, Kathmandu Municipality and manufacturing plant at Sudal of Bhaktapur.
